重组人NUDCD2蛋白; 重组人NUDT1蛋白; 重组人NUDT10蛋白; 重组人NUDT14蛋白; 重组人NUDT16蛋白; 重组人NUDT16L1蛋白; 重组人NUDT2蛋白; 重组人NUDT21蛋白; 重组人NUDT3蛋白; 重组人NUDT4蛋白; 重组人NUDT5蛋白; 重组人NUDT9蛋白; 重组人NUP62CL蛋白; 重组大肠杆菌NusA蛋白; 重组人NUTF2蛋白; 重组人NXPH1蛋白; 重组人NXT1蛋白; 重组人NXT2蛋白; 重组人OAS1蛋白; 重组人OAT蛋白; 重组人OAZ1蛋白; 重组人OBFC1蛋白; 重组人OCIAD2蛋白; 重组人OCT4蛋白; 重组大肠杆菌sodA蛋白; 重组人ODC1蛋白; 重组人OGG1蛋白; 重组人OLA1蛋白; 重组人OLFM1蛋白; 重组人OLR1蛋白; 重组人OMG蛋白; 重组人OMP蛋白; 重组人OPTC蛋白; 重组人ORAOV1蛋白; 重组人ORC6蛋白; 重组人ORM蛋白; 重组人ORM2蛋白; 重组人OSCAR蛋白; 重组人OSGEP蛋白; 重组人OSM蛋白; 重组人OSR2蛋白; 重组人Osteopontin蛋白; 重组人Osteoprotegerin/TNFRSF11B蛋白; 重组人OSTF1蛋白; 重组人OSTN蛋白; 重组人OTC蛋白; 重组人OTOR蛋白; 重组人OTUB2蛋白; 重组人Otubain 1蛋白; 重组人OVCA2蛋白; 重组人OXLD1蛋白; 重组人OXSM蛋白; 重组人OXSR1蛋白; 重组人P4HB蛋白; 重组小鼠P4HB蛋白; 重组人PA1蛋白; 重组人PA2G4蛋白; 重组人PABPN1蛋白; 重组PAEP蛋白; 重组人PAFAH1B3蛋白; 重组人PAFAH2蛋白; 重组人PAICS蛋白; 重组人PAIP2蛋白; 重组人PAK4蛋白; 重组人PALM蛋白; 重组人PAPSS1蛋白; 重组Parathyroid Hormone蛋白; 重组人PARD6B蛋白; 重组人PARK2蛋白; 重组小鼠Park7蛋白; 重组人PARP1蛋白; 重组人PARP2蛋白; 重组人PARVA蛋白; 重组人PAX8蛋白; 重组人PAX9蛋白; 重组人PBK蛋白; 重组人PBLD蛋白; 重组人PCBD1蛋白; 重组人PCBP1蛋白; 重组人PCDHGC4蛋白; 重组人PCID2蛋白; 重组人PCK1蛋白; 重组人PCMT蛋白; 重组人PCMTD1蛋白; 重组人PCNA蛋白; 重组人PCNP蛋白; 重组人PCOLCE蛋白; 重组人PCP4L1蛋白; 重组人PCSK1N蛋白; 重组人PCYT2蛋白; 重组人PDAP1蛋白; 重组人PDCD1LG2蛋白; 重组人PDCD4蛋白; 重组人PDCD5蛋白; 重组人PDCD6蛋白; 重组人PDCL蛋白; 重组人PDCL3蛋白; 重组人PDE6D蛋白; 重组人PDGFB蛋白; 重组人PDGFD蛋白; 重组人PDGFRa蛋白; 重组人PDHX蛋白; 重组人PDIA3蛋白; 重组人PDIA4蛋白; 重组人PDIA6蛋白; 重组人PDK1蛋白; 重组人PDLIM1蛋白; 重组人PDPN蛋白; 重组人PDRG1蛋白; 重组人PDXK蛋白; 重组人PDXP蛋白; 重组人PDZD11蛋白; 重组人PDZK1蛋白; 重组人PEA-15蛋白; 重组人PEBP1蛋白; 重组小鼠Pebp1蛋白; 重组人PECI蛋白; 重组人PECR蛋白; 重组人PED6H蛋白; 重组人PEDF蛋白; 重组人PEF1蛋白; 重组人PELI2蛋白; 重组人Pentraxin 3蛋白; 重组人PEPD蛋白; 重组人Peroxiredoxin 2蛋白; 重组人Peroxiredoxin 3蛋白; 重组人Peroxiredoxin 5蛋白; 重组人Peroxiredoxin 6蛋白; 重组人PET117蛋白; 重组人PEX19蛋白; 重组人PEX26蛋白; 重组人PF4V1蛋白; 重组人PFDN1蛋白; 重组人PFDN2蛋白; 重组人PFDN4蛋白; 重组人PFDN5蛋白; 重组人PFDN6蛋白; 重组人PFKM蛋白; 重组大鼠Pfn1蛋白; 重组人PFN2蛋白; 重组人PGAM1蛋白; 重组小鼠PGAM1蛋白; 重组人PGAM2蛋白; 重组人PGC蛋白; 重组人PGD蛋白; 重组小鼠Pgf蛋白; 重组人PGK1蛋白; 重组小鼠Pgk1蛋白; 重组人PGK2蛋白; 重组人PGLS蛋白; 重组人PGM1蛋白; 重组人PGM2蛋白; 重组人PGP蛋白; 重组人PGP9.5蛋白; 重组人PGPEP1蛋白; 重组人PHB蛋白; 重组人PHB2蛋白; 重组人PHF11蛋白; 重组人PHF13蛋白; 重组人PHF5A蛋白; 重组人PHLDA2蛋白; 重组人PHOSPHO1蛋白; 重组人PHOSPHO2蛋白; 重组人Phosphoserine phosphatase蛋白; 重组人PHPT1蛋白; 重组大肠杆菌phrB蛋白; 重组人PI3蛋白; 重组人PICK1蛋白; 重组人PIH1D1蛋白; 重组人PIH1D2蛋白; 重组人PIM1蛋白; 重组人PIM2蛋白; 重组人Pin 1(Peptidyl-prolyl cis/trans isomerase)蛋白; 重组小鼠Pin1蛋白; 重组人PIN4蛋白; 重组人PINK1蛋白; 重组人PINX1蛋白; 重组人PIP蛋白; 重组人PIP4K2B蛋白; 重组人PIR蛋白; 重组人PITPNB蛋白; 重组PKCK2蛋白; 重组人PKIB蛋白; 重组人PKLR蛋白; 重组人PKM2蛋白; 重组人PKNOX1蛋白; 重组人PLA1A蛋白; 重组人PLA2G7蛋白; 重组人PLAC8蛋白; NudC domain-containing protein 2; DKFZp686E10109; NudC domain containing protein 2; 8-dihydro-8-oxoguanine triphosphatase; MTH1; 8-oxo-dGTPase; Nudix motif 1; Diphosphoinositol polyphosphate phosphohydrolase 3-alpha; APS2; DIPP3a; hDIPP3alpha; Uridine diphosphate glucose pyrophosphatase; UGPP; UGPPase; Nudix type motif 16; Protein syndesmos; MGC11275; SDOS; bis(5'-nucleosyl)-tetraphosphatase [asymmetrical].APAH1; MGC10404; Nudix (nucleoside diphosphate linked moiety X)-type motif 21; CFIM25; CPSF5; DKFZp686H1588; Nudix (nucleoside diphosphate linked moiety X)-type motif 3; DIPP; DIPP1; Diphosphoinositol polyphosphate phosphohydrolase 2; DIPP2; DIPP2alpha; DIPP2beta; HDCMB47P; ADP-sugar pyrophosphatase; hYSAH1; YSA1; YSA1H; ADP-ribose pyrophosphatase; mitochondrial isoform a; MGC3037; NUDT10; NUP62CL protein; FLJ20130; RP13-383K5.2; Transcription termination/antitermination L factor; ECK3158; JW3158; Nuclear transport factor 2; NTF2; Placental protein 15; PP15; Neurexophilin-1; NXPH1; Nbla00697; NPH1; NTF2-related export protein 1; MTR2; P15; NTF2-related export protein 2; P15-2; 2’; 5’-oligoadenylate synthetase 1; isoform2; IFI-4; OIAS; OIASI; ornithine aminotransferase precursor; DKFZp781A11155; HOGA; OATASE; Ornithine decarboxylase antizyme 1; AZI; OAZ; CST complex subunit STN1; AAF-44; RPA-32; STN1; OCIA domain-containing protein 2 isoform 1; MGC45416; OCIA domain-containing protein 2; Ovarian carcinoma immunoreactive antigen-like protein; POU domain; class 5; transcription factor 1 isoform 2; POU5F1; MGC22487; OCT3; OCT4; OTF3; OTF4; Superoxide dismutase; manganese; MnSOD; Ornithine decarboxylase; ODC; 8-oxoguanine DNA glycosylase 1; HMMH; HOGG1; MUTM; OGH1; AP lyase; Obg-like ATPase 1; DOC45; GBP45; GTBP9; GTPBP9; PTD004; Noelin isoform 2; olfactomedin 1; AMY; NOE1; NOELIN1; OlfA; Oxidized low density lipoprotein(lectin-like)receptor 1; CLEC8A; LOX1; SCARE1; Oxidized low-density lipoprotein receptor 1 isoform 1; OLR1; hLOX-1; LOXIN; SLOX1; Oligodendrocyte-myelin glycoprotein; OMG; OMGP; OMGP_HUMAN; Olfactory marker protein; olfactory neuronal-specific protein; Opticin; OPT; Oral cancer-overexpressed protein 1; TAOS1; Origin recognition complex subunit 6; ORC6L; Alpha-1-acid glycoprotein 1; Orosomucoid-1; ORM; AGP1; AGP-A; Alpha-1-acid glycoprotein 2; orosomucoid 2; AGP-B; AGP2; ORM2; AGP-B'; Osteoclast-associated immunoglobulin-like receptor isoform 1; PIGR3; probable tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP; GCPL1; KAE1; OSGEP1; PRSMG1; Oncostatin M; protein odd-skipped-related 2 isoform b; OSR2 - odd-skipped related 2 (Drosophila); FLJ90037; OPN; SPP-1; BNSP; BSPI; ETA-1; Tumor necrosis factor receptor superfamily; member 11b; Osteoclastogenesis inhibitory factor; OPG; OCIF; Osteoclast stimulating factor 1; SH3P2; OSF; Osteocrin; Musclin; Ornithine carbamoyltransferase; OCTD; OTCase; Otoraplin; FDP; MIAL1; Ubiquitin thioesterase OTUB2; OTB2; OTU2; Otubain 1; 1-271 aa; Human; His-tagged; Recombinant; E.coli; Ovarian tumor suppressor candidate 2; Ovarian cancer-associated gene 2 protein; Oxidoreductase-like domain-containing protein 1; C17orf90; 3-oxoacyl-ACP synthase; mitochondrial; FASN2D; KASI; KS; Serine/threonine-protein kinase OSR1; KIAA1101; OSR1; Oxidative stress-responsive 1 protein; Serine threonine-protein kinase OSR1; Prolyl 4-hydroxylase subunit beta; P4Hbeta; PDI; PDIA1; PHD; PO4DB; PO4HB; ERBA2L; P4HB; ERp59; Thbp; PAXIP1-associated protein 1; FLJ22459; GAS; MGC4606; C16orf53; Proliferation-associated protein 2G4; EBP1; HG4-1; p38-2G4; OPMD; PAB2; PABII; PABP-2; PABP2; Glycodelin precursor; GD; GdA; GdF; GdS; PAEG; PEP; PP14; Platelet-activating factor acetylhydrolase IB subunit gamma; PAFAHG; PAF-AH1b alpha 1 subunit; Platelet-activating factor acetylhydrolase 2; cytoplasmic; HSD-PLA2; Multifunctional protein ADE2; ADE2; ADE2H1; AIRC; PAIS; Poly(A)-binding protein-interacting protein 2; PAIP2A; PABP- interacting protein 2; HSPC218; p21-activated kinase 4 isoform 1; p21 protein (Cdc42/Rac)-activated kinase 4; Paralemmin-1 isoform 1; Paralemmin; Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1; ATPSK1; PAPSS; SK1; PTH; PTH1; Partitioning defective 6 homolog beta; PAR6B; E3 ubiquitin-protein ligase parkin; AR-JP; LPRS2; PDJ; PRKN; DJ-1; Dj1; Poly (ADP-ribose) polymerase family; member 1; ADPRT; ADPRT1; pADPRT; pADPRT-1; PARP; PARP-1; PPOL; Poly (ADP-ribose) polymerase 2; ADPRT2; ADPRTL2; ADPRTL3; ARTD2; pADPRT-2; PARP-2; Alpha-parvin; CH-ILKBP; MXRA2; Paired box protein Pax-8 isoform PAX8E; paired box 8; Paired box protein Pax-9; STHAG3; Lymphokine-activated killer T-cell-originated protein kinase; CT84; Nori-3; SPK; TOPK; Phenazine biosynthesis-like domain-containing protein; FLJ14767; MAWBP; MAWDBP; Pterin-4-alpha-carbinolamine dehydratase; DCOH; PCBD; PCD; PHS; Poly(rC) binding protein 1; hnRNP-E1; hnRNP-X; HNRPE1; HNRPX; protocadherin gamma-C4 isoform 2 precursor; PCDH-GAMMA-C4; PCI domain containing 2; DKFZp686C20226; F10; FLJ11305; FLJ99362; MGC16774; RP11-98F14.6; Phosphoenolpyruvate carboxykinase 1; PEPCK-C; PEPCK1; PEPCKC; Protein-L-isoaspartate O-methyltransferase; Protein-L-isoaspartate O-methyltransferase domain-containing protein 1; 0; Proliferating cell nuclear antigen; PEST proteolytic signal containing nuclear protein; DKFZp781I24156; Procollagen C-endopeptidase enhancer 1; PCPE; PCPE-1; PCPE1; Purkinje cell protein 4-like protein 1; IQM1; ProSAAS precursor; Proprotein convertase subtilisin/kexin type 1 inhibitor; PROSAAS; SAAS; Ethanolamine-phosphate cytidylyltransferase isoform 2; ET; PDGFA associated protein 1; HASPP28; PAP; PAP1; Programmed cell death 1 ligand 2; B7DC; bA574F11.2; Btdc; CD273; PD-L2; PDCD1L2; PDL2; PDCD1LG2; Programmed cell death 4 isoform 1; Neoplastic transformation inhibitor; H731; Programmed cell death 5; TFAR19; Programmed cell death protein 6; ALG-2; PEF1B; Phosducin-like protein; PhLP; Phosducin-Like protein 3; HTPHLP; MGC3062; PHLP2A; PHLP3; VIAF; VIAF1; Retinal rod rhodopsin-sensitive cGMP 3'; 5'-cyclic phosphodiesterase subunit delta; PDED; Platelet-derived growth factor subunit B isoform 2; c-sis; IBGC5; PDGF-2; PDGF2; SIS; SSV; Platelet-derived growth factor D; IEGF; MSTP036; SCDGF-B; SCDGFB; Platelet-derived growth factor receptor alpha precursor; CD140A; PDGFR2; MGC74795; Rhe-PDGFRA; Pyruvate dehydrogenase protein X component; DLDBP; E3BP; OPDX; PDX1; proX; ER60; ERp57; ERp60; ERp61; GRP57; GRP58; HsT17083; P58; PI-PLC; Protein disulfide-isomerase A4; Endoplasmic reticulum resident protein 72; ERP70; ERP72; ERP5; P5; TXNDC7; Pyruvate dehydrogenase kinase; isozyme 1; PDZ and LIM domain protein 1; CLIM1; CLP-36; CLP36; Hclim1; Lung type-I cell membrane-associated glycoprotein isoform a; Podoplanin; T1A; GP36; GP40; Gp38; OTS8; T1A-2; HT1A-1; PA2.26; p53 and DNA-damage regulated 1; C20orf126; PDRG; Pyridoxal kinase; PKH; PNK; PRED79; Pyridoxine kinase; Pyridoxal phosphate phosphatase; CIN; PLP; PLPP; PDZ domain-containing protein 11; AIPP1; PDZK11; PISP; Na(+)/H(+) exchange regulatory cofactor NHE-RF3; CAP70; CLAMP; NHERF-3; NHERF3; PDZD1; Phosphoprotein enriched in astrocytes; 15kD; Astrocytic phosphoprotein PEA-15; PEA15; PED; Phosphatidylethanolamine binding protein 1; HCNP; PBP; PEBP; Pbp1; Pbqr; Rkip; Peroxisomal 3; 2-trans-enoyl-CoA isomerase; ACBD2; DRS1; HCA88; Peroxisomal trans-2-enoyl-CoA reductase; DCRRP; HPDHASE; HSA250303; PVIARL; SDR29C1; TERP; Retinal cone rhodopsin-sensitive cGMP 3'; 5'-cyclic phosphodiesterase subunit gamma; ACHM6; RCD3; Pigment epithelium-derived factor; EPC-1; PIG35; SERPINF1; Penta-EF-hand domain containing 1; ABP32; PEF1A; E3 ubiquitin-protein ligase pellino homolog 2; PELI2 - pellino E3; Pellino-2; TNFAIP5; TSG-14; Xaa-Pro dipeptidase isoform 1; PROLIDASE; NKEFB; PRP; PRX2; PRXII; TDPX1; TSA; PRDX2; Thioredoxin-dependent peroxide reductase; PRDX3; PRX III; Antioxidant protein 1 (AOP-1); ACR1; AOEB116; B116; PMP20; PRDX6; PRXV; SBBI10; 1-Cys; aiPLA2; AOP2; NSGPx; p29; PRX; Protein PET117 homolog; Peroxisomal biogenesis factor 19; D1S2223E; HK33; PMP1; PMPI; PXF; PXMP1; Peroxisome assembly protein 26; PBD7A; PBD7B; PEX26M1T; Pex26pM1T; Platelet factor 4 variant; CXCL4L1; CXCL4V1; PF4-ALT; PF4A; SCYB4V1; Prefoldin subunit 1; PDF; PFD1; Prefoldin subunit 2; PFD2; HSPC231; Prefoldin subunit 4; Protein C-1; PFD4; Prefoldin subunit 5 isoform alpha; MM-1; MM1; PFD5; Prefoldin subunit 6; H2-KE2; HKE2; KE-2; MGC70744; PFD6; 6-Phosphofructokinase; muscle type; GSD7; PFK-1; PFK1; PFKA; PFKX; 0; Profilin 2; PFL; Phosphoglycerate mutase 1; Phosphoglycerate mutase isozyme B; PGAM-B; PGAMA; 2310050F24Rik; Pgam-1; Phosphoglycerate mutase 2; GSD10; PGAM-M; PGAMM; Gastricsin; PGC; PEPC; PGII; PEPC_HUMAN; pepsin C; Pepsinogen C; pepsinogen group II; preprogastricsin; Progastricsin; Phosphogluconate dehydrogenase; 6PGD; AI854365; PIGF; Plgf; Phosphoglycerate kinase 1; MGC117307; MGC142128; MGC8947; MIG10; PGKA; Pgk-1; Phosphoglycerate kinase 2; dJ417L20.2; PGKB; PGKPSS; 6-phosphogluconolactonase; 6PGL; CDG1T; GSD14; Phosphoglucomutase-2; Phosphoglucomutase 2; MSTP006; Phosphoglycolate phosphatase; PGPase; Ubiquitin carboxyl-terminal esterase L1; UCHL1; PARK5; Uch-L1; Pyroglutamyl-peptidase 1; Pyroglutamyl-peptidase I; Pcp; PGP; PGP-I; PGPI; Prohibitin; PHB1; Prohibitin 2; BAP; Bap37; BCAP37; p22; PNAS-141; REA; PHD finger protein 11; APY; BCAP; IGEL; IGER; IGHER; NY-REN-34; NYREN34; RP11-185C18.3; PHD finger protein 13; PHF5; SPOC1; PHD finger-like domain-containing protein 5A; PHD finger protein 5A; bK223H9.2; INI; Rds3; SAP14b; SF3b14b; Pleckstrin homology-like domain family A member 2; BRW1C; BWR1C; HLDA2; IPL; TSSC3; Phosphoethanolamine/phosphocholine phosphatase; Pyridoxal phosphate phosphatase PHOSPHO2; PSPH; PSP; 14 kDa phosphohistidine phosphatase; bA216L13.10; CGI-202; DKFZp564M173; HSPC141; PHP14; RP11-216L13.10; 14 kDa phosphohistidine phosphatas; Deoxyribodipyrimidine photolyase; ECK0697; JW0698; phrB; Elafin preproprotein; Cementoin; ESI; SKALP; WAP3; WFDC14; Elafin; PRKCA-binding protein; Protein interacting with PRKCA 1; PICK; PRKCABP; PIH1 domain-containing protein 1; NOP17; PIH1 domain-containing protein 2; PIH1 domain containing 2; Non-specific serine/threonine protein kinase; PIM; Serine/threonine-protein kinase pim-2; pim-2 oncogene; Protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1; NIMA-interacting protein 1; DOD; UBL5; Rotamase Pin1; PPIase Pin1; Peptidyl-prolyl cis-trans isomerase NIMA-interacting1; 0610025L01Rik; D9Bwg1161e; Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 isofom 2; Parvulin-14; Parvulin-17; PPIase Pin4; hEPVH; PAR14; PAR17; Serine/threonine-protein kinase PINK1; BRPK; FLJ27236; PARK6; PIN2-interacting protein 1; TRF1-interacting protein 1; Liver-related putative tumor suppressor; Protein 67-11-3; LPTL; LPTS; Prolactin-inducible protein; GCDFP-15; GCDFP15; GPIP4; Phosphatidylinositol 5-phosphate 4-kinase type-2 beta; PI5P4KB; PIP5K2B; PIP5KIIB; PIP5KIIbeta; Pirin; Probable quercetin 2; 3-dioxygenase PIR; Phosphatidylinositol transfer protein beta isoform; PI-TP-beta; PtdInsTP beta; VIB1B; Casein kinase II alpha 1 subunit isoform a; CSNK2A1; CK2A1; CKII; cAMP-dependent protein kinase inhibitor beta; FLJ23817; PRKACN2; Pyruvate kinase isozymes R/L; PK1; PKL; PKR; PKRL; RPK; Pyruvate kinase; muscle isoform M2; CTHBP; THBP1; M2-PK; Tumor M2-PK; PK2; PK3; PKM; Hmeobox protein PKNOX1; pkonx1c; PREP1; Phospholipase A1 member A; PS-PLA1; PSPLA1; Platelet-activating factor acetylhydrolase precursor; LDL-PLA2; LP-PLA2; PAFAD; PAFAH; Placenta-specific 8; C15; onzin